About us

Services

See all services
Social Impact
  • Sustainability
  • Inclusion
  • Pro Bono
    • Innovation
  • LCA Ventures
  • Legal Tech
  • Smart Collaboration

    • People

    Practice
  • Administrative Law
  • Corporate
  • Criminal Law
  • Crisis Management
  • Environmental
  • Family
  • Finance
  • IP and Advertising
  • IT & Data Protection
  • Labour and Trade Union Relations
  • Litigation, Arbitration and ADR
  • Tax
    • Industry
  • Art
  • Energy
  • Fashion & Luxury
  • Food & Beverage
  • Gaming & Esports
  • Insurance
  • Life Sciences
  • Manufacturing
  • Private Clients
  • Real Estate
  • Sport
  • Technology, Media & AI
  • Third Sector
  • Transport, Shipping & Aviation
    • Desk
  • China desk
  • French desk
  • German desk
  • MENA desk
    • Your Legal Counsel
  • Your Legal Counsel
    • PREVIOUS
    NEXT
    Insight | 27.03.2020

    Covid-19: regulatory steps taken by AIFA in relation to the pharmacological treatment of the desease

    Marketing & Communication
    marketing@lcalex.it

    COVID-19 represents a new pathogenic element for the whole world. Consequently, to date, there are no specific therapies to cure or prevent it, as no medicine has been studied for the treatment of this specific Coronavirus.

    AIFA (Italian Medicines Agency) therefore established a specific crisis unit and intervened by taking various initiatives to face the emergency.

    The Life Science Team analyzed them in the new Alert.

    Read it here!

    Contacts

    Equity Partner
    Leonardo De Vecchi
    Equity Partner
    Marina Rosito
    Partner
    Dario Covucci
    Equity Partner
    Nicola Maffioletti
    Marketing & Communication
    marketing@lcalex.it
    Life Sciences

    Life Sciences

    Also in the Life Sciences industry, our dedicated team combines cross-departmental skills and expertise to support a wider range of clients. We work with entrepreneurs, institutions, investors and domestic and international funds operating in the Life Science and Healthcare fields, providing full multi-disciplinary assistance, based on the experience and the real and in-depth knowledge of the specific issues of this industry.
    LINK

    You might also be interested in
    News
    26.03.2025
    The Legal 500 (EMEA) 2025 – LCA Studio Legale

    New Legal 500 rankings released. LCA confirms the positive trend with achievements in both practice/industry and person ...

    News
    20.03.2025
    Chambers Europe & Global 2025 – LCA Studio Legale

    LCA strengthens its position in the Chambers and Partners rankings

    News
    04.02.2025
    LCA with Dealfa in the acquisition of a patent portfolio from Akeso

    LCA advised Dealfa on the acquisition of a patent portfolio in the medical device sector.